TABLE 1.
Baseline disease characteristics and demographics
| Parameter | Total (N = 15) |
|---|---|
| Sex, n (%) | |
| Male | 13 (86.7) |
| Female | 2 (13.3) |
| Race, n (%) | |
| White | 15 (100.0) |
| Ethnicity, n (%) | |
| Not Hispanic or Latino | 15 (100.0) |
| Mean age, years (SD) | 58.2 (9.8) |
| Mean body weight, kg (SD) | 93.9 (14.9) |
| Mean BMI, kg/m2 (SD) | 30.8 (2.4) |
| Mean HbA1c, % (SD) | 6.9 (1.1) |
| Mean duration of diabetes, years (SD) | 3.1 (1.8) |
| Concomitant medications at screening, n (%) | |
| Anticholinergics: tropicamide | 12 (80.0) |
| Biguanides: metformin | 12 (80.0) |
| Statins: | 4 (26.7) |
| Atorvastatin | 3 (20.0) |
| Simvastatin | 1 (6.7) |
| Dihydropyridine derivatives: amlodipine | 3 (20.0) |
| ACE inhibitors: ramipril | 2 (13.3) |
| Angiotensin II antagonists: losartan | 1 (6.7) |
| Combinations and complexes of aluminium, calcium and magnesium compounds: calcium carbonate, calcium phosphate, kaolin, magnesium carbonate, magnesium hydroxide, magnesium oxide | 1 (6.7) |
| Multivitamins: vitamins not otherwise specified | 1 (6.7) |
| Unspecified herbal and traditional medicine: krill oil | 1 (6.7) |
| Vitamin A and D combination: cod liver oil | 1 (6.7) |
Abbreviations: ACE, angiotensin‐converting enzyme; BMI, body mass index; SD, standard deviation.